US scientists have developed a potential new treatment for the management of HIV. A research team led by Benson Edagwa and Howard Gendelman have converted a monthly drug into a yearly injection. “This pharmaceutical development has the potential to not only treat, but also prevent viral infection.
This may certainly be a therapeutic milestone” said Professor Gendelman. The University of Nebraska scientists chemically converted cabotegavir (CAB), a monthly pill and injectable medication, into a